Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Oncology Reports
|
April 8, 2015
Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells
Takanobu Motoshima, Yoshihiro Komohara, Hasita Horlad, et al.
Oncology Reports
|
April 6, 2005
ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients
Shigeki Shichijo, Yuki Ishihara, Kouichi Azuma, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|
April 23, 2013
Fas-deficient fully allogeneic dendritic cells administered via an intratumoral injection route show efficient antitumor effects in murine models
Shinji Okano, Haruhiko Kondoh, Takeo Toshima, et al.
The Prostate
|
September 21, 2004
Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients
Masanori Noguchi, Kyogo Itoh, Akihisa Yao, et al.
Cancer Science
|
November 29, 2008
Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide-using non-myeloablative allogeneic hematopoietic cell transplantation
Masumitsu Hamaguchi, Masatoshi Eto, Yoriyuki Kamiryo, et al.
International Immunopharmacology
|
March 4, 2014
Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma
Takafumi Minami, Tomoko Minami, Nobutaka Shimizu, et al.
International Immunopharmacology
|
January 23, 2017
Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24<sup>+</sup> patients with renal cell carcinoma
Takafumi Minami, Naoki Matsumura, Koichi Sugimoto, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|
April 23, 2013
CD4 T cell-mediated masking effects of the immunogenicity of tumor-associated antigens are qualitatively and quantitatively different depending on the individual antigens
Shinji Okano, Yoshihiro Matsumoto, Shohei Yoshiya, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 12, 2015
Identification of Programmed Death Ligand 1-derived Peptides Capable of Inducing Cancer-reactive Cytotoxic T Lymphocytes From HLA-A24+ Patients With Renal Cell Carcinoma
Takafumi Minami, Tomoko Minami, Nobutaka Shimizu, et al.
Pediatric Surgery International
|
February 12, 2024
The expression analysis of SerpinB9 in hepatoblastoma microenvironment
Hiroki Hirao, Ahmad Adawy, Lianbo Li, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Oncology Reports
|
April 8, 2015
Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells
Takanobu Motoshima, Yoshihiro Komohara, Hasita Horlad, et al.
Oncology Reports
|
April 6, 2005
ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients
Shigeki Shichijo, Yuki Ishihara, Kouichi Azuma, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|
April 23, 2013
Fas-deficient fully allogeneic dendritic cells administered via an intratumoral injection route show efficient antitumor effects in murine models
Shinji Okano, Haruhiko Kondoh, Takeo Toshima, et al.
The Prostate
|
September 21, 2004
Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients
Masanori Noguchi, Kyogo Itoh, Akihisa Yao, et al.
Cancer Science
|
November 29, 2008
Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide-using non-myeloablative allogeneic hematopoietic cell transplantation
Masumitsu Hamaguchi, Masatoshi Eto, Yoriyuki Kamiryo, et al.
International Immunopharmacology
|
March 4, 2014
Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma
Takafumi Minami, Tomoko Minami, Nobutaka Shimizu, et al.
International Immunopharmacology
|
January 23, 2017
Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24<sup>+</sup> patients with renal cell carcinoma
Takafumi Minami, Naoki Matsumura, Koichi Sugimoto, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|
April 23, 2013
CD4 T cell-mediated masking effects of the immunogenicity of tumor-associated antigens are qualitatively and quantitatively different depending on the individual antigens
Shinji Okano, Yoshihiro Matsumoto, Shohei Yoshiya, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 12, 2015
Identification of Programmed Death Ligand 1-derived Peptides Capable of Inducing Cancer-reactive Cytotoxic T Lymphocytes From HLA-A24+ Patients With Renal Cell Carcinoma
Takafumi Minami, Tomoko Minami, Nobutaka Shimizu, et al.
Pediatric Surgery International
|
February 12, 2024
The expression analysis of SerpinB9 in hepatoblastoma microenvironment
Hiroki Hirao, Ahmad Adawy, Lianbo Li, et al.
Page
of 11